(11/03/2024)vs COBALT | 40 | 27 | 5 / 5100% | 5 / 771.4% | 4 / 1428.6% | 9 / 2142.9% | | 2 | 13 | 0 | 13 | 5 | 6 | 1 | 2 | 38 |
(05/03/2024)vs PHARMACIA | 26 | 20 | 0 / 00% | 1 / 425% | 6 / 1250% | 7 / 1643.8% | | 3 | 11 | 0 | 11 | 0 | 2 | 2 | 2 | 24 |
(20/02/2024)vs NETCOMPANY INTRASOFT | 40 | 28 | 9 / 1275% | 2 / 366.7% | 5 / 1241.7% | 7 / 1546.7% | | 1 | 9 | 0 | 9 | 5 | 2 | 1 | 3 | 31 |
(05/02/2024)vs ΔΙΚ. ΣΥΛ. ΠΕΙΡΑΙΑ | 40 | 44 | 14 / 1782.4% | 3 / 560% | 8 / 2236.4% | 11 / 2740.7% | | 1 | 11 | 2 | 13 | 5 | 4 | 0 | 3 | 44 |
(16/01/2024)vs Σ.Ε.Ε.Τ.Τ. | 40 | 39 | 7 / 887.5% | 1 / 520% | 10 / 1952.6% | 11 / 2445.8% | | 3 | 13 | 1 | 14 | 5 | 5 | 0 | 3 | 46 |
(12/12/2023)vs PHARMACIA | 18 | 7 | 2 / 2100% | 1 / 333.3% | 1 / 616.7% | 2 / 922.2% | | 2 | 5 | 1 | 6 | 2 | 3 | 0 | 1 | 10 |
(05/12/2023)vs NICKAN | 40 | 35 | 12 / 12100% | 4 / 757.1% | 5 / 1631.3% | 9 / 2339.1% | | 2 | 12 | 3 | 15 | 4 | 1 | 0 | 5 | 36 |
(21/11/2023)vs Σ.Ε.ΤΑΠ. | 36 | 26 | 1 / 250% | 2 / 728.6% | 7 / 1741.2% | 9 / 2437.5% | | 3 | 13 | 2 | 15 | 6 | 1 | 1 | 4 | 29 |
(14/11/2023)vs ΔΙΚ. ΣΥΛ. ΠΕΙΡΑΙΑ | 26 | 30 | 13 / 1492.9% | 4 / 757.1% | 3 / 1421.4% | 7 / 2133.3% | | 5 | 13 | 1 | 14 | 3 | 5 | 0 | 1 | 36 |
(06/11/2023)vs LP CLINIC | 40 | 37 | 12 / 1485.7% | 8 / 1942.1% | 3 / 1127.3% | 11 / 3036.7% | | 0 | 13 | 9 | 22 | 6 | 3 | 2 | 6 | 43 |
(31/10/2023)vs ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ BC | 40 | 45 | 13 / 13100% | 4 / 1233.3% | 8 / 2040% | 12 / 3237.5% | | 2 | 16 | 0 | 16 | 4 | 4 | 1 | 5 | 45 |
(17/10/2023)vs UNISYSTEMS | 33 | 32 | 6 / 6100% | 4 / 580% | 6 / 1637.5% | 10 / 2147.6% | | 1 | 12 | 2 | 14 | 7 | 4 | 0 | 2 | 44 |
ΣΥΝΟΛΙΚΑ |
419 |
370 |
94 / 10589.5% |
39 / 8446.4% |
66 / 17936.9% |
105 / 26339.9% |
|
25 |
141 |
21 |
162 |
52 |
40 |
8 |
37 |
426 |
ΜΕΣΟΙ ΟΡΟΙ |
34.9 |
30.8 |
7.8 / 8.889.5% |
3.2 / 746.4% |
5.5 / 14.936.9% |
8.8 / 21.939.9% |
|
2.1 |
11.8 |
1.8 |
13.5 |
4.3 |
3.3 |
0.7 |
3.1 |
35.5 |